Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Kei Kurata"'
Publikováno v:
Nephron Extra, Vol 7, Iss 3, Pp 78-88 (2017)
Nephron Extra
Nephron Extra
Background/Aim: High serum alkaline phosphatase (ALP) levels predict mortality independent of bone metabolism parameters and liver function test results in patients on hemodialysis. The relationship between serum ALP at dialysis initiation and mortal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fd1da832b72112a753a1b614ba5055c
https://www.karger.com/Article/FullText/481409
https://www.karger.com/Article/FullText/481409
Autor:
Hirotake Kasuga, Hirofumi Tamai, Yasuhiko Ito, Masashi Mizuno, Satoko Kido, Kei Kurata, Teppei Matsuoka, Satoshi Suzuki, Hideaki Shimizu, Fumiko Sakata, Tomohiko Naruse, Yosuke Saka, Takeyuki Hiramatsu, Norimi Ohashi, Hisashi Kurata, Masanobu Horie, Makoto Mizutani, Seiichi Matsuo, Yoshikazu Tsuruta, Shoichi Maruyama, Yasuhiro Suzuki
Publikováno v:
Clinical and Experimental Nephrology. 20(6):960-970
Background: Early withdrawal within 3 years after starting peritoneal dialysis (PD) and PD-related peritonitis have been major obstacles preventing increases in the population of PD patients. To address these problems, we implemented education progra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91613343f6b8d5ff06d4307612ff2c1e
https://nagoya.repo.nii.ac.jp/records/23523
https://nagoya.repo.nii.ac.jp/records/23523
Publikováno v:
Nihon Toseki Igakkai Zasshi. 48:123-128
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7f6db6ba1051d9de2a291a45a43f6ba
https://doi.org/10.4009/jsdt.48.123
https://doi.org/10.4009/jsdt.48.123
Autor:
Yoshinari Yasuda, Tomohiko Naruse, Waichi Sato, Rhohei Yamamoto, Shoichi Maruyama, Izumi Sakamoto, Yoshiki Morita, Naotake Tsuboi, Enyu Imai, Miho Tatematsu, Seiichi Matsuo, Kei Kurata
Publikováno v:
Clinical and Experimental Nephrology. 16:883-891
Pozzi et al. reported the effectiveness of steroid pulse therapy (Pozzi’s regimen) in IgA nephropathy (IgAN). The present study was performed to clarify the predictive factors for IgAN patients treated with Pozzi’s regimen. One hundred nine IgAN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c3a0549d82e2ab532451f16c503066e
https://doi.org/10.1007/s10157-012-0644-0
https://doi.org/10.1007/s10157-012-0644-0
Autor:
Miho Tatematsu, Kei Kurata, Minako Murata, Sho Sendo, Yutaka Kamimura, Sachiyo Sugiura, Kyoko Hamaguchi, Yukio Yuzawa, Seiichi Matsuo, Hiroshi Nagaya, Daijo Inaguma, Akimitsu Kitagawa
Publikováno v:
Clinical and Experimental Nephrology. 14:43-50
Besides its effect on calcium metabolism, vitamin D may play a part in preventing the onset and progression of cardiovascular disease (CVD) events. Only a few reports on the studies relating to whether vitamin D may reduce CVD events in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acfc377e55f263fa826ad58dd16dc274
https://doi.org/10.1007/s10157-009-0233-z
https://doi.org/10.1007/s10157-009-0233-z
Autor:
Sachiyo Suzuki, Kei Kurata, Miho Tatematsu, Hibiki Shinjo, Daijo Inaguma, Hiroshi Nagaya, Tomoko Mishima, Kazuhiro Hara
Publikováno v:
Clinical and Experimental Nephrology. 12:126-131
It is known that vitamin D has many functions besides involvement in calcium metabolism. It has recently been recognized that vitamin D deficiency is associated with mortality, especially in cardiovascular disease (CVD). Vitamin D deficiency is commo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b00f7d751bc2db7748e76116debaf62d
https://doi.org/10.1007/s10157-007-0023-4
https://doi.org/10.1007/s10157-007-0023-4
Autor:
Seiichi Matsuo, Miho Tatematsu, Yukio Yuzawa, Shinichiro Inaba, Daijo Inaguma, Kei Kurata, Sachiyo Suzuki, Tomoko Mishima, Hibiki Shinjo
Publikováno v:
Clinical and Experimental Nephrology. 11:56-60
As hypertension and diabetes mellitus increase, the number of patients developing complications of cardiovascular disease (CVD) associated with conventional risk factors is increasing. In addition to these risk factors for CVD, chronic kidney disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::422ddeb1541cd9587ddd8a799fbb5a87
https://doi.org/10.1007/s10157-006-0443-6
https://doi.org/10.1007/s10157-006-0443-6
Autor:
Yasuhiko Ito, Yukio Yuzawa, Yoshiki Morita, Toshitaka Nabeshima, Sawako Kato, Waichi Sato, Masashi Mizuno, Shoichi Maruyama, Takenori Ozaki, Atsumi Nitta, Kei Kurata, Seiichi Matsuo, Junichiro Yamamoto
Publikováno v:
American journal of physiology. Renal physiology. 297(6)
Peritoneal fibrosis (PF) is an important complication of peritoneal dialysis therapy. The present study was performed to examine the mechanisms of PF in view of the plasminogen activator (PA)/plasmin/matrix metalloproteinase (MMP) cascade. PF was ind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70e5a9e8bea383b4a9f36f7da4835611
https://pubmed.ncbi.nlm.nih.gov/19934446
https://pubmed.ncbi.nlm.nih.gov/19934446
Autor:
Yukio Yuzawa, Yutaka Kamimura, Akimitsu Kitagawa, Hiroshi Nagaya, Kyoko Hamaguchi, Sachiyo Suzuki, Kei Kurata, Seiichi Matsuo, Minako Murata, Daijo Inaguma, Miho Tatematsu
Publikováno v:
Clinical and experimental nephrology. 14(2)
Darbepoetin alfa, which has a much longer half-life than recombinant human erythropoietin, is used to treat renal anemia. However, there are few reports investigating the efficacy of darbepoetin alfa administered every 2 weeks (Q2W).We performed the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::823188858f246bfdd31d6fcb6a796df7
https://pubmed.ncbi.nlm.nih.gov/19967423
https://pubmed.ncbi.nlm.nih.gov/19967423
Autor:
Miho Tatematsu, Daijo Inaguma, Sachiyo Suzuki, Kei Kurata, Hibiki Shinjo, Shinichiro Inaba, Tomoko Mishima
Publikováno v:
Clinical and experimental nephrology. 10(4)
The purpose of the treatment and management of chronic renal failure during the predialysis period is mainly to retard the progression of the deterioration of renal function. Optimal dialysis initiation is important to improve the patient's outcome a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbc6ba7c5a21d164e9a073f3c303b14f
https://pubmed.ncbi.nlm.nih.gov/17186332
https://pubmed.ncbi.nlm.nih.gov/17186332